Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer
The clinical trial update assesses the prognostic value of PET/CT imaging for tumor progression in patients with metastatic hormone-sensitiv…
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer [NA]
Clinical trial evaluating transrectal perilesional biopsy for diagnosing prostate cancer has completed.
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial [NA]
Clinical trial update for the Robotic Prostatectomy AI Low Pressure Pain (RALP) trial indicating it is not yet recruiting for prostate cance…
-
CLINICAL_TRIALS research · 2025-04-08Clinical Trial Update: Focal Laser Ablation in Prostate Cancer
Ain Shams University is conducting a clinical trial on focal laser ablation for prostate cancer; the study is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the radioligand therapy [161Tb]Tb-PSMA-I&T in men with metastatic castration-resistant prostate cancer…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-06Clinical Trial Update: PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer [EARLY_Phase 1]
Clinical trial update for PSMA and C-11 Choline PET in patients with biochemical recurrence of prostate cancer; the EARLY Phase 1 study has …
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique [NA]
A clinical trial is evaluating a simultaneous dual-nuclide PET/CT imaging technique. The study is not yet recruiting and is sponsored by Xij…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: Prehabilitation in Prostate Cancer Patients, TelePrehabTrial [NA]
The TelePrehabTrial is an active but not recruiting clinical trial studying prehabilitation in prostate cancer patients, with the University…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy [Phase 3]
Phase 3 clinical trial evaluating androgen deprivation therapy added to radiotherapy for oligo-recurrent prostate cancer; current status is …
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: Analysis of Immediate Urinary Continence Predictors After RS-RARP
Clinical trial update describing analysis of predictors for immediate urinary continence after Retzius-sparing robot-assisted radical prosta…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum
A completed clinical trial evaluating an AI platform that integrates imaging data and predictive models to support precision care across the…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: The Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical Prostatectomy [NA]
A clinical trial update on using somatosensory interactive pelvic floor muscle training to treat stress urinary incontinence in men after ra…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors [Phase 2]
A Phase 2 study of seribantumab in adults with NRG1 gene fusion-positive advanced solid tumors has been terminated, with results posted in A…
-
EMA approval · 2025-04-03EMA Authorised: Camcevi (leuprorelin mesilate) — Accord Healthcare S.L.U.
The EMA authorised Camcevi containing leuprorelin mesilate for prostatic neoplasms (prostate cancer) in the EU, with Accord Healthcare S.L.U…
-
CLINICAL_TRIALS trial_result · 2025-04-03Clinical Trial Update: Focal Prostate Ablation Versus Radical Prostatectomy [NA]
A completed clinical trial comparing focal prostate ablation with radical prostatectomy for prostate cancer.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)
An ongoing clinical trial (Low-PRISM) is evaluating the use of low-field MRI for monitoring prostate cancer. The study is currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: ES-HIFU, Prospective Data Collection of Patients Treated With Partial Gland HIFU Ablation for Prostate Cancer
Clinical trial evaluating ES-HIFU partial gland ablation for prostate cancer has been terminated.
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Comparative Performance of 64Copper [64Cu]-SAR-bis-PSMA vs 68Ga PSMA-11 PET CT for the Detection of Prostate Cancer Recurrence in the Setting of Biochemical Failure Following Radical Prostatectomy [Phase 2]
Phase 2 trial comparing 64Cu-SAR-bis-PSMA and 68Ga-PSMA-11 PET CT for detecting recurrence of prostate cancer after radical prostatectomy is…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment [NA]
This document provides an update on an ongoing clinical trial evaluating nurse-led proactive telephone follow-up for patients after completi…
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: Otago Exercises on the Risk of Falling in Prostatic Cancer Patients Receiving Androgen Deprivation Therapy [NA]
A completed clinical trial evaluated Otago exercises to reduce the risk of falling in patients with prostate cancer receiving androgen depri…
-
CLINICAL_TRIALS withdrawal · 2025-04-01Clinical Trial Update: Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancer [Phase 1]
A Phase 1 trial evaluating autologous T cells engineered to express L1CAM-specific CARs for locally advanced, unresectable, or metastatic sm…
-
CLINICAL_TRIALS research · 2025-03-31Clinical Trial Update: The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA) [NA]
A clinical trial assessing whether PSMA PET imaging adds value for detecting clinically significant prostate cancer lesions in patients unde…
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating oxybutynin for hot flashes in men undergoing hormone therapy for prostate cancer has completed and posted …
-
CLINICAL_TRIALS trial_result · 2025-03-30Clinical Trial Update: Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer [Phase 2]
A Phase 2 trial in men with advanced prostate cancer compares the combination of cediranib and olaparib to olaparib alone, with results post…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy [Phase 1, Phase 2]
Phase 1/2 study of a personalized PSMA radiopharmaceutical therapy for prostate cancer is not yet recruiting. The trial includes metastatic …